XML 12 R2.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 4,728,776 $ 5,872,767
Advances and deposits on clinical programs and other current assets 2,162,469 2,136,192
Total current assets 6,891,245 8,008,959
Property and equipment (at cost, less accumulated depreciation and amortization) 676,565 541,272
Other assets:    
Operating lease right-of-use assets, net 1,170,517 1,117,133
Deposits and other assets 50,000 50,000
Total other assets 1,220,517 1,167,133
Total assets 8,788,327 9,717,364
Current liabilities:    
Accounts payable – trade 1,735,568 1,300,026
Other accrued liabilities 3,199,502 3,033,747
Operating lease liabilities - current portion 382,217 452,358
Total current liabilities 5,317,287 4,786,131
Operating lease liabilities - non-current portion 811,190 686,935
Total liabilities 6,128,477 5,473,066
Commitments and contingencies
Stockholders’ equity:    
Preferred stock - $0.01 par value (100,000 shares authorized and no shares issued or outstanding at June 30, 2025 and December 31, 2024
Common stock - $0.01 par value (112,500,000 shares authorized; 1,717,502 and 966,714 shares issued at June 30, 2025 and December 31, 2024, respectively; and 1,717,500 and 966,712 shares outstanding at June 30, 2025 and December 31, 2024, respectively) 17,175 9,667
Additional paid-in capital 416,373,961 411,122,863
Accumulated deficit (413,646,098) (406,803,044)
Total stockholders’ equity before treasury stock 2,745,038 4,329,486
Treasury stock, at cost (2 shares at June 30, 2025 and December 31, 2024) (85,188) (85,188)
Total stockholders’ equity 2,659,850 4,244,298
Total liabilities and stockholders’ equity $ 8,788,327 $ 9,717,364